Volume 88, Issue 4, Pages (October 2015)

Slides:

Advertisements

Similar presentations

Epidemiology of end-stage renal disease: International comparisons of renal replacement therapy Francesco Paolo Schena Kidney International Volume 57,

Advertisements

Changing Incidence and Outcomes Following Dialysis-Requiring Acute Kidney Injury Among Critically Ill Adults: A Population-Based Cohort Study Ron Wald,

From: Assessment of Neutrophil Gelatinase-associated Lipocalin in the Brain-dead Organ Donor to Predict Immediate Graft Function in Kidney Recipients:A.

Intensive hemodialysis—keeping the faith

Propofol-related green urine

Drug use and nephrotoxicity in the intensive care unit

End-stage renal disease in developing countries

Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure Steven Fishbane, Nobuyuki Miyawaki Kidney International

Stem cells for kidney repair: useful tool for acute renal failure?

Summary of Recommendation Statements

Volume 75, Issue 3, Pages (February 2009)

The cardiac surgery–associated neutrophil gelatinase-associated lipocalin (CSA-NGAL) score: A potential tool to monitor acute tubular damage Hilde R.H.

Zaccaria Ricci, Claudio Ronco, Sergio Picardo Kidney International

Volume 60, Issue 2, Pages (August 2001)

Intensive hemodialysis—keeping the faith

Continuous renal replacement therapy in the critically ill patient

Reassessment of the care of the patient with chronic kidney disease

Section 5: Dialysis Interventions for Treatment of AKI

Volume 77, Issue 1, Pages 6-8 (January 2010)

Need for better diabetes treatment for improved renal outcome

Volume 80, Issue 4, Pages (August 2011)

Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy? Fu L. Luan, Diane E. Steffick,

Volume 83, Issue 5, Pages (May 2013)

Volume 84, Issue 4, Pages (October 2013)

End-stage renal disease in living kidney donors

Comorbidity and confounding in end-stage renal disease

Volume 68, Issue 1, Pages (July 2005)

Volume 91, Issue 3, Pages (March 2017)

Response to ‘Hepcidin levels in patients with renal disease’

The promise of biomarkers for personalized renal cancer care

Volume 78, Issue 2, Pages (July 2010)

Volume 76, Issue 6, Pages (September 2009)

Volume 87, Issue 1, Pages (January 2015)

Volume 70, Issue 7, Pages (October 2006)

Volume 76, Issue 6, Pages (September 2009)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Volume 74, Issue 8, Pages (October 2008)

Alternate-day dialysis may be needed for hemodialysis patients

Volume 87, Issue 5, Pages (May 2015)

Starting dialysis is dangerous: how do we balance the risk?

Nephrology Crossword: Glomerulonephritis

Volume 79, Issue 10, Pages (May 2011)

V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Volume 80, Issue 3, Pages (August 2011)

A man with a hole in his penis

Volume 73, Issue 9, Pages (May 2008)

Volume 82, Issue 9, Pages (November 2012)

Volume 81, Issue 12, Pages (June 2012)

Volume 60, Issue 3, Pages (September 2001)

Does equal care give equal outcomes?

Volume 75, Pages S47-S49 (February 2009)

Volume 80, Issue 10, Pages (November 2011)

American Indian heritage and risk factors for renal injury

Volume 76, Issue 1, Pages 8-10 (July 2009)

Is complement a target for therapy in renal disease?

David A. Ferenbach, David C. Kluth, Jeremy Hughes Kidney International

Volume 75, Pages S50-S51 (February 2009)

Pediatric acute kidney injury: The use of the RIFLE criteria

Volume 86, Issue 2, Pages (August 2014)

Renal prognosis of toxigenic Escherichia coli infection

Volume 87, Issue 3, Pages (March 2015)

Volume 81, Issue 8, Pages (April 2012)

Antioxidant therapy in hemodialysis patients: a systematic review

Volume 57, Issue 2, Pages (October 2000)

Global trends in the rates of living kidney donation

Rajni Singhal, Janet E. Hux, Shabbir M H Alibhai, Matthew J. Oliver

Volume 79, Issue 10, Pages (May 2011)

Volume 68, Issue 4, Pages (October 2005)

Presentation transcript:

Volume 88, Issue 4, Pages 897-904 (October 2015) Comparison of standard and accelerated initiation of renal replacement therapy in acute kidney injury Ron Wald, Neill K.J. Adhikari, Orla M. Smith, Matthew A. Weir, Karen Pope, Ashley Cohen, Kevin Thorpe, Lauralyn McIntyre, Francois Lamontagne, Mark Soth, Margaret Herridge, Stephen Lapinsky, Edward Clark, Amit X. Garg, Swapnil Hiremath, David Klein, C. David Mazer, Robert M.A. Richardson, M. Elizabeth Wilcox, Jan O. Friedrich, Karen E.A. Burns, Sean M. Bagshaw Kidney International Volume 88, Issue 4, Pages 897-904 (October 2015) DOI: 10.1038/ki.2015.184 Copyright © 2015 International Society of Nephrology Terms and Conditions

Figure 1 Patient flow through the trial. *Reasons for non-enrollment included participation in other trials (n=2), discharge from ICU (n=2), lack of NGAL supplies (n=2), nephrology team not available (n=1), lack of health insurance (n=1). ICU, intensive care unit; NGAL, neutrophil gelatinase-associated lipocalin; RRT, renal replacement therapy; SDM, substitute decision maker. Kidney International 2015 88, 897-904DOI: (10.1038/ki.2015.184) Copyright © 2015 International Society of Nephrology Terms and Conditions

Figure 2 Time from eligibility to renal replacement therapy (RRT) initiation stratified by treatment strategy (P<0.0001). Kidney International 2015 88, 897-904DOI: (10.1038/ki.2015.184) Copyright © 2015 International Society of Nephrology Terms and Conditions